Metlife (NYSE:MET) had its price target increased by Deutsche Bank from $46.00 to $47.00 in a research note issued to investors on Friday, Stock Target Advisor reports. They currently have a hold rating on the financial services provider’s stock.

A number of other equities research analysts have also recently weighed in on the company. Sandler O’Neill raised Metlife from a hold rating to a buy rating in a report on Wednesday, January 2nd. Wells Fargo & Co reaffirmed a buy rating on shares of Metlife in a report on Tuesday, January 8th. ValuEngine raised Metlife from a sell rating to a hold rating in a report on Wednesday, January 16th. Bank of America raised Metlife from a neutral rating to a buy rating and set a $44.06 price target on the stock in a report on Wednesday, January 16th. Finally, Royal Bank of Canada cut their price target on Metlife from $57.00 to $50.00 and set an outperform rating on the stock in a report on Monday, December 17th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company’s stock. Metlife has a consensus rating of Hold and a consensus target price of $52.76.

Shares of MET stock opened at $45.25 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.14 and a quick ratio of 0.14. Metlife has a 52 week low of $37.76 and a 52 week high of $48.92. The company has a market capitalization of $43.57 billion, a price-to-earnings ratio of 8.40, a P/E/G ratio of 0.98 and a beta of 1.18.

Metlife (NYSE:MET) last released its quarterly earnings results on Wednesday, February 6th. The financial services provider reported $1.35 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.05. The company had revenue of $15.40 billion for the quarter, compared to analysts’ expectations of $15.84 billion. Metlife had a return on equity of 10.24% and a net margin of 7.53%. The business’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.64 earnings per share. On average, analysts predict that Metlife will post 5.48 earnings per share for the current fiscal year.

In related news, CFO John D. Mccallion sold 2,669 shares of the business’s stock in a transaction that occurred on Tuesday, February 12th. The stock was sold at an average price of $44.43, for a total transaction of $118,583.67. Following the sale, the chief financial officer now owns 20,538 shares of the company’s stock, valued at $912,503.34. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Steven J. Goulart sold 10,292 shares of the business’s stock in a transaction that occurred on Tuesday, February 12th. The stock was sold at an average price of $44.40, for a total value of $456,964.80. Following the sale, the executive vice president now directly owns 93,214 shares in the company, valued at approximately $4,138,701.60. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

A number of large investors have recently made changes to their positions in the stock. BlackRock Inc. increased its holdings in shares of Metlife by 1.2% in the fourth quarter. BlackRock Inc. now owns 72,555,303 shares of the financial services provider’s stock valued at $2,979,118,000 after buying an additional 853,018 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Metlife by 8.4% in the fourth quarter. Bank of New York Mellon Corp now owns 13,981,487 shares of the financial services provider’s stock valued at $574,078,000 after buying an additional 1,087,142 shares in the last quarter. Oregon Public Employees Retirement Fund increased its holdings in shares of Metlife by 4,191.8% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 12,828,417 shares of the financial services provider’s stock valued at $312,000 after buying an additional 12,529,511 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Metlife by 7.4% in the fourth quarter. Geode Capital Management LLC now owns 12,421,536 shares of the financial services provider’s stock valued at $509,344,000 after buying an additional 856,479 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Metlife by 9.0% in the fourth quarter. Northern Trust Corp now owns 11,458,240 shares of the financial services provider’s stock valued at $470,475,000 after buying an additional 947,261 shares in the last quarter. 76.85% of the stock is currently owned by hedge funds and other institutional investors.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Further Reading: Net Asset Value

Analyst Recommendations for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.